In obese patients, an increased level of leptin was associated with the low-grade inflammatory state, which resulted in cardiovascular diseases, degenerative disease, type II diabetes, and autoimmune disease in this group of patients [39,40]. Here, LEP is linked to cardiovascular disorder.